Draavin Pharma Private Limited

Draavin Pharma Private Limited - trading in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U85300MH2013PTC241684 Incorporated 03 April 2013 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company trading
Revenue · FY 2024
₹800
▼ 99% YoY
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2025
Balance sheet date
Last AGM
30 Sep 2025
Annual general meeting

About Draavin Pharma Private Limited

Data last updated:

Draavin Pharma Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 03 April 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85300MH2013PTC241684. Its GSTIN is 27AAECD6460A1ZZ (Maharashtra).

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Shrikant Shivdas Ugale and Debu Sardar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 02 B – Wing Anandvan Chs Anand Park Majiwada, Thane, Maharashtra, India – 400601.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U85300MH2013PTC241684
Registration Number 241684
Incorporation Date 03 April 2013
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Draavin Pharma Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    02 B – Wing Anandvan Chs Anand Park Majiwada, Thane, Maharashtra, India – 400601
  • Industry
    Trading, Other Wholesale, Wholesale

To see the full contact details of Draavin Pharma Private Limited, buy the company report.

Comprehensive company report
Draavin Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Draavin Pharma Private Limited

FY 2025 filings available

Draavin Pharma Private Limited reported revenue of ₹800 (down 99% YoY) for FY 2024.

Revenue · FY 2024
₹800 ▼ 99%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 99%
3 years · compounded
▼ 66%
5 years · compounded
▼ 72%

Revenue has declined at a compounded annual rate (CAGR) of 72% over five years, including a 99% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Draavin Pharma Private Limited, buy the company report.

Board of directors of Draavin Pharma Private Limited

Draavin Pharma has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors

Auditor

Draavin Pharma Private Limited is audited by V. R. Gambhir& Associates for the financial year 2017.

Auditor firmFinancial yearFirm registration number
V. R. Gambhir& AssociatesFY 2017119748W

Shareholding

The shareholding of Draavin Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Draavin Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Draavin Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Draavin Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAECD6460A1ZZMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Draavin Pharma Private Limited, buy the company report.

Recent activity

Draavin Pharma Private Limited has 10 board changes on record since 2013: 6 appointments and 4 cessations. The latest: Debu Sardar was appointed as Director on 24 Jan 2026.

Appointed
Debu Sardar was appointed as Director.
Appointed
Shrikant Shivdas Ugale was appointed as Director.
AGM
Draavin Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Anurag Jagannath Sharma ceased to be Director.
Ceased
Sarita Sushilkumar Tripathi ceased to be Director.
Appointed
Kishor Manna was appointed as Director.
Appointed
Timir Ranjan Sarkar was appointed as Director.
Filing
Draavin Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Shivmani Rammani Tiwari ceased to be Director.
Appointed
Sarita Sushilkumar Tripathi was appointed as Director.
Ceased
Rajesh Suresh Dubey ceased to be Director.
Appointed
Anurag Jagannath Sharma was appointed as Director.

1 earlier event is in the company report.

Frequently asked questions

Draavin Pharma is an active private limited company based in Thane, Maharashtra, India. The company works in other wholesale, within the trading industry. It was incorporated on 03 April 2013 (13+ years old) and is registered under CIN U85300MH2013PTC241684.

Draavin Pharma has 2 current directors:

The latest financial statements of Draavin Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Draavin Pharma is 27AAECD6460A1ZZ, registered in Maharashtra.

The CIN (Corporate Identification Number) of Draavin Pharma is U85300MH2013PTC241684. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Draavin Pharma was incorporated on 03 April 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.

Debu Sardar was appointed as Director on 24 Jan 2026. Shrikant Shivdas Ugale was appointed as Director on 11 Oct 2025. Anurag Jagannath Sharma ceased to be Director on 17 Jul 2025. Draavin Pharma has 10 board changes on record in total.

The registered office of Draavin Pharma is at 02 B – Wing Anandvan Chs Anand Park Majiwada, Thane, Maharashtra, India – 400601.

Draavin Pharma operates in the trading industry, in the other wholesale segment.

The compliance status of Draavin Pharma is compliant as of 31 August 2026. The company is actively filing with the Registrar of Companies.